NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. The company reported quarterly sales of $19.256 million which beat the analyst consensus estimate of $18.297 million by 5.24 percent. This is a 16.63 percent increase over sales of $16.510 million the same period last year.
NeuroPace Q2 2024 GAAP EPS $(0.26) Beats $(0.31) Estimate, Sales $19.256M Beat $18.297M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated